Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 11.0 | 34 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 13.0 | 51 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 13.0 | 38 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 14.0 | 33 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 14.0 | 49 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 15.0 | 45 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | SDF1-a | 15.0 | 40 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 13.0 | 43 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 15.0 | 56 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 17.0 | 51 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 16.0 | 45 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 13.5 | 42 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 16.0 | 45 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 14.5 | 54 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 16.0 | 57 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 13.0 | 37 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 15.0 | 41 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 18.0 | 36 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 17.0 | 29 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 15.0 | 50 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 24.5 | 34 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 19.0 | 35 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | SDF1-a | 22.0 | 38 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SDF1-a | 12.0 | 49 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SDF1-a | 11.0 | 53 |